Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

ESGO 2021 | Importance of real-world data on patient outcomes

Name: Importance of real-world data on patient outcomes
Uploaded: 2021-10-26T00:00:00Z
Duration: 2 min 19 s
Description: Vimalanand Prabhu, PhD, Merck, Lansdale, PA, discusses possible sources and uses of real-world data, and compares this style of study to randomized clinical trials. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Vimalanand Prabhu • 26 Oct 2021

ESGO 2021

Endometrial Cancer General Gynecological Cancer

Vimalanand Prabhu, PhD, Merck, Lansdale, PA, discusses possible sources and uses of real-world data, and compares this style of study to randomized clinical trials. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

Disclosures

Vimalanand Prabhu is an employee of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA and shareholder of Merck & Co., Inc., Kenilworth, NJ, USA.